Advertisement
Screener

PHATHOM PHARMACEUTICALS, INC. (PHAT) Auditor

PHATHOM PHARMACEUTICALS, INC. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-26: Fiscal year end 2025-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Iselin, New Jersey.
  • 2025-03-06: Fiscal year end 2024-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Iselin, New Jersey.
  • 2024-06-14: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Iselin, New Jersey.
  • 2024-03-07: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Iselin, New Jersey.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-262025-12-31Ernst & Young LLP42Iselin, New JerseyNo
2025-03-062024-12-31Ernst & Young LLP42Iselin, New JerseyNo
2024-06-142023-12-31Ernst & Young LLP42Iselin, New JerseyNo
2024-03-072023-12-31Ernst & Young LLP42Iselin, New JerseyNo
2023-02-282022-12-31Ernst & Young LLP42Iselin, New JerseyNo
2022-03-012021-12-31Ernst & Young LLP42Iselin, New JerseyNo
2021-03-302020-12-31Ernst & Young LLPSan Diego, CaliforniaNo
2020-03-192019-12-31Ernst & Young LLPSan Diego, California

Similar stocks

Stock NameCountryMarket CapPE Ratio
Altimmune, Inc. (ALT)United States$0.593B-6.43
Monopar Therapeutics (MNPR)United States$0.598B-34.82
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
CorMedix Inc. (CRMD)United States$0.605B3.25
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Evolus, Inc. (EOLS)United States$0.519B-13.32
Neurogene Inc. (NGNE)$0.625B-4.46